Anti-TfR antibodies and their use in treating proliferative and inflammatory disorders
US11230605B2 · kind B2 · utility
42Cited by
3References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 2016 |
| Grant date | Jan 25, 2022 |
| Priority date | — |
| Expiry date | May 10, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to humanized antibodies that specifically bind to human transferrin receptor and their use in treating cancer and inflammatory disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.